Mechanism identified for drug resistance in glioblastoma brain tumors
Duke Health researchers have identified a unique process within the environment of deadly brain tumors that drives resistance to immune-boosting therapies and could be targeted to promote the effects of those drugs.
Nov 3, 2022
0
41